Date Initiated by Firm | March 25, 2015 |
Date Posted | June 02, 2015 |
Recall Status1 |
Terminated 3 on January 24, 2017 |
Recall Number | Z-1703-2015 |
Recall Event ID |
71273 |
510(K)Number | K760318 |
Product Classification |
Activated partial thromboplastin - Product Code GFO
|
Product | Dade Actin Activated Cephaloplastin Reagent; Liquid rabbit brain cephalin with plasma activator for use in the determination of the activated partial thromboplastin time (APTT) and other coagulation procedures requiring an activated partial thromboplastin reagent. |
Code Information |
Catalog Number B4218-1, Material Number 10445709, lot numbers 557128, 557129, 557130, 557131, 557132, 557133, 557134, 557135, 557140, 557141 , expiration dates:10/31/2015, 11/21/2015, 2/16/2016 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 Gbc Dr Ms 514 PO BOX 6101 Newark DE 19702-2466
|
For Additional Information Contact | Customer Support 800-441-9250 |
Manufacturer Reason for Recall | Recovery for assayed controls are out of assigned ranges. A drift >3 seconds in the normal APTT range and/or >15% in the pathological range has been observed. Patient samples with recoveries close to the medical decision points could exhibit a deviation up to 4 seconds for the normal range and up to 33% for the pathological range. |
FDA Determined Cause 2 | Under Investigation by firm |
Action | On March 24, 2015 an Urgent Medical Device Recall letter was mailed to all affected customers to notify them about the issue, associated risks, and actions to be taken. |
Quantity in Commerce | 27501 |
Distribution | Worldwide Distribution. US naionwide including Puerto Rico, Barbados and Mexico. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = GFO
|